Biodesix Issuance Of Capital Stock from 2010 to 2025

BDSX Stock  USD 0.67  0.04  5.63%   
Biodesix Issuance Of Capital Stock yearly trend continues to be fairly stable with very little volatility. Issuance Of Capital Stock will likely drop to about 43.9 M in 2025. During the period from 2010 to 2025, Biodesix Issuance Of Capital Stock regression line of annual values had r-squared of  0.55 and arithmetic mean of  24,443,734. View All Fundamentals
 
Issuance Of Capital Stock  
First Reported
2010-12-31
Previous Quarter
55.6 M
Current Value
43.9 M
Quarterly Volatility
23.7 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Biodesix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biodesix's main balance sheet or income statement drivers, such as Interest Income of 25.9 K, Depreciation And Amortization of 3.2 M or Interest Expense of 6.9 M, as well as many indicators such as Price To Sales Ratio of 2.64, Dividend Yield of 0.0 or PTB Ratio of 7.36. Biodesix financial statements analysis is a perfect complement when working with Biodesix Valuation or Volatility modules.
  
Check out the analysis of Biodesix Correlation against competitors.
For more information on how to buy Biodesix Stock please use our How to Invest in Biodesix guide.

Latest Biodesix's Issuance Of Capital Stock Growth Pattern

Below is the plot of the Issuance Of Capital Stock of Biodesix over the last few years. It is Biodesix's Issuance Of Capital Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Biodesix's overall financial position and show how it may be relating to other accounts over time.
Issuance Of Capital Stock10 Years Trend
Slightly volatile
   Issuance Of Capital Stock   
       Timeline  

Biodesix Issuance Of Capital Stock Regression Statistics

Arithmetic Mean24,443,734
Geometric Mean16,221,354
Coefficient Of Variation97.11
Mean Deviation20,713,759
Median8,500,000
Standard Deviation23,738,364
Sample Variance563.5T
Range63.5M
R-Value0.74
Mean Square Error271.8T
R-Squared0.55
Significance0
Slope3,697,203
Total Sum of Squares8452.6T

Biodesix Issuance Of Capital Stock History

202543.9 M
202455.6 M
202356.9 M
202259.5 M
202116.7 M
202072 M
201910 M

About Biodesix Financial Statements

Biodesix investors use historical fundamental indicators, such as Biodesix's Issuance Of Capital Stock, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Biodesix. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Issuance Of Capital Stock55.6 M43.9 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Biodesix Stock Analysis

When running Biodesix's price analysis, check to measure Biodesix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biodesix is operating at the current time. Most of Biodesix's value examination focuses on studying past and present price action to predict the probability of Biodesix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biodesix's price. Additionally, you may evaluate how the addition of Biodesix to your portfolios can decrease your overall portfolio volatility.